Skip to main content
. 2024 Sep 16;24:981. doi: 10.1186/s12879-024-09880-2

Table 3.

Performance of SpeeDx and TIB Molbiol using bayesian latent class model (BLCM)

Model with all Patients Model with Patients diagnosed with Gonorrhea
Mycoplasma positivity (95% CrI) 3.3(2.5–4.5) 4.2(2.0–7.2)
SpeeDx
Sensitivity (95% CrI) 84.1(74.3–92.0) 78.5(63.0–92.3)
Specificity (95% CrI) 98.3(97.6–99.0) 97.6(95.6–99.0)
TIB Molbiol
Sensitivity (95% CrI) 83.8(74.0–91.7) 78.9(59.2–93.6)
Specificity (95% CrI) 98.9(98.3–99.4) 96.8(94.6–98.5)

CrI: Credible interval